Cite

HARVARD Citation

    Nakano, K. et al. (2019). Incidence and risk factors of interstitial lung disease of patients with head and neck cancer treated with cetuximab. Head & neck. 41 (8), pp. 2574-2580. [Online]. 
  
Back to record